You are currently viewing a new version of our website. To view the old version click .

Lymphatics, Volume 3, Issue 1

March 2025 - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Review
  • Open Access
1 Citations
3,020 Views
28 Pages

The central conducting lymphatics (CCL) and mesenteric lymphatic systems are responsible for lipid absorption, fluid regulation, and protein delivery into the bloodstream. Disruptions in these systems can result in debilitating conditions such as chy...

  • Article
  • Open Access
1,372 Views
11 Pages

Gata3 Insufficiency Accelerates Recanalization of Damaged Lymphatics via Adjusting Collagen Composition

  • Moyuru Hayashi,
  • Takuya Harada,
  • Jun Takai,
  • Satoshi Uemura,
  • Takashi Moriguchi,
  • Tomomi Watanabe-Asaka and
  • Yoshiko Kawai

The impaired repair of lymphatic vessels after tissue damage is an etiological hallmark of lymphedema. Previously, we demonstrated that lymphatic recanalization after the popliteal lymph node extirpation was delayed in Gata2 heterozygous mice. This i...

  • Article
  • Open Access
1,184 Views
11 Pages

Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia

  • Christian Omar Ramos Peñafiel,
  • Adolfo Martínez Tovar,
  • Daniela Pérez Sámano,
  • Rafael Cerón Maldonado,
  • Adán Germán Gallardo Rodríguez,
  • Carlos Martínez Murillo and
  • Irma Olarte Carrillo

Background/Objectives: The prognosis of acute lymphoblastic leukemia has significantly improved with the incorporation of innovative therapies such as immunotherapy, tyrosine kinase inhibitors, and CAR-T cell-based treatments. Drug resistance, mediat...

  • Article
  • Open Access
1 Citations
2,441 Views
16 Pages

Outcomes and Prognostic Assessment of Post-Transplant Lymphoproliferative Disorder: 20-Year Experience

  • Hira Shaikh,
  • Zulfa Omer,
  • Koffi Wima,
  • Tara Magge,
  • Shimul A. Shah and
  • Tahir Latif

Post-transplant lymphoproliferative disorder (PTLD) is the most common malignancy in adults who receive solid organ transplantation (SOT), apart from skin cancer. It is a serious and potentially fatal complication of chronic immunosuppression (ISI) i...

  • Review
  • Open Access
2,525 Views
10 Pages

Lymphatic malformations (LMs) are benign, congenital vascular anomalies caused by abnormal lymphangiogenesis during embryology, often presenting as fluid-filled cystic lesions. Though LMs can affect any part of the body except the brain, they primari...

  • Article
  • Open Access
1,152 Views
11 Pages

Introduction: Studies on the association between immune-mediated disorders and lymphoid disorders have been very limited, especially in diverse populations. The objective of this study is to evaluate the relationship between a variety of immune disea...

  • Review
  • Open Access
1 Citations
6,219 Views
24 Pages

Advancements in Multiple Myeloma Therapies: A Comprehensive Review by Disease Stage

  • Hager Hisham El Khatib,
  • Kanz Abdulla,
  • Layla Khaled Nassar,
  • Mariam Gouda Ellabban and
  • Andreas Kakarougkas

Multiple myeloma is an incurable hematologic malignancy arising from plasma cells. The uncontrolled growth of monoclonal plasma cells leads to an abnormal overproduction of immunoglobulins. The recommended course of treatment for MM is according to d...

  • Review
  • Open Access
3,507 Views
8 Pages

The soluble interleukin-2 receptor (sIL-2R) is a novel biomarker associated with a variety of immune-mediated diseases. It is produced through the proteolytic cleavage of the membrane-bound interleukin-2 receptor α-chain on activated T lymphocy...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Lymphatics - ISSN 2813-3307